2019 Full year and fourth quarter
We announced our 2019 full year and fourth quarter results on Wednesday 05 February.
2013 Third Quarter - released 23 October 2013
Simon Dingemans, CFO, discusses our third quarter results 2013.
2013 Second Quarter - released 24 July 2013
Simon Dingemans, CFO, discusses our second quarter results 2013.
2013 First Quarter - released 24 April 2013
Simon Dingemans, CFO, discusses our first quarter results 2013.
2012 Fourth Quarter - released 06 February 2013
Simon Dingemans, CFO, and Sir Andrew Witty, CEO, discuss our fourth quarter results 2012.
- Core EPS of 112.7p and returns of £6.3bn to shareholders
- 2012 dividend of 74p (+6%)
- Group sales -1%; flat excluding disposals of OTC brands
- Successful R&D delivery: six new drugs filed since start of 2012
Other key information
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
Keep up to date with our news and recent announcements
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business
We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients and payers